secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000064803-24-000033
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q3 GAAP EPS $0.07, Adjusted EPS $1.09; records $1.1B premium deficiency reserve
--------------------------------------------------------------------------------

- Total revenues $95.4B (+6.3% YoY); GAAP diluted EPS $0.07 vs $1.75 prior year.
- Adjusted EPS $1.09 vs $2.21 prior year; operating income $832M down from $3.69B.
- Health Care Benefits segment recorded ~$1.1B premium deficiency reserves ($0.63/share) for Medicare and individual exchange.
- Year-to-date cash flow from operations $7.2B; CEO highlights strong Health Services and Pharmacy segments but challenges in Health Care Benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000033/0000064803-24-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000033/cvs-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000064803-24-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer